Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan
· Delayed Price · Currency is TWD 84.60
+0.20 (0.24%)
Apr 25, 2025, 1:30 PM CST
Excelsior Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 24, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 13,823 | 14,052 | 13,757 | 10,019 | 8,130 | 7,918 | Upgrade
|
| Market Cap Growth | 2.15% | 2.15% | 37.31% | 23.23% | 2.67% | 14.64% | Upgrade
|
| Enterprise Value | 12,690 | 11,054 | 14,022 | 9,593 | 6,612 | 7,442 | Upgrade
|
| Last Close Price | 84.60 | 82.29 | 77.33 | 54.30 | 41.72 | 38.21 | Upgrade
|
| PE Ratio | 18.00 | 18.22 | 18.43 | 15.01 | 13.39 | 13.85 | Upgrade
|
| PS Ratio | 1.62 | 1.65 | 1.67 | 1.39 | 1.24 | 1.19 | Upgrade
|
| PB Ratio | 1.22 | 1.24 | 1.26 | 0.97 | 0.83 | 0.83 | Upgrade
|
| P/TBV Ratio | 1.55 | 1.58 | 1.61 | 1.23 | 1.06 | 1.05 | Upgrade
|
| P/FCF Ratio | 5.87 | 5.96 | - | 21.52 | 10.42 | 9.44 | Upgrade
|
| P/OCF Ratio | 5.59 | 5.69 | 128.44 | 15.73 | 8.60 | 9.11 | Upgrade
|
| EV/Sales Ratio | 1.49 | 1.30 | 1.70 | 1.34 | 1.01 | 1.12 | Upgrade
|
| EV/EBITDA Ratio | 9.23 | 11.68 | 16.19 | 12.94 | 9.21 | 12.08 | Upgrade
|
| EV/EBIT Ratio | 11.79 | 14.67 | 19.95 | 15.81 | 11.11 | 14.07 | Upgrade
|
| EV/FCF Ratio | 5.38 | 4.69 | - | 20.61 | 8.47 | 8.87 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.13 | 0.08 | 0.08 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 1.36 | 1.36 | 1.49 | 0.98 | 0.96 | 1.03 | Upgrade
|
| Debt / FCF Ratio | 0.61 | 0.61 | - | 1.74 | 0.98 | 0.85 | Upgrade
|
| Asset Turnover | 0.44 | 0.44 | 0.48 | 0.46 | 0.45 | 0.48 | Upgrade
|
| Inventory Turnover | 5.12 | 5.12 | 5.45 | 5.48 | 5.90 | 6.30 | Upgrade
|
| Quick Ratio | 1.27 | 1.27 | 1.38 | 1.44 | 1.66 | 1.86 | Upgrade
|
| Current Ratio | 1.47 | 1.47 | 1.60 | 1.66 | 1.88 | 2.12 | Upgrade
|
| Return on Equity (ROE) | 8.72% | 8.72% | 8.70% | 7.84% | 7.47% | 7.35% | Upgrade
|
| Return on Assets (ROA) | 2.45% | 2.45% | 2.54% | 2.40% | 2.56% | 2.38% | Upgrade
|
| Return on Capital (ROIC) | 3.75% | 3.75% | 3.74% | 3.51% | 3.58% | 3.24% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.20% | 6.20% | 6.20% | 5.70% | 5.90% | 5.30% | Upgrade
|
| Earnings Yield | 5.58% | 5.49% | 5.43% | 6.66% | 7.47% | 7.22% | Upgrade
|
| FCF Yield | 17.05% | 16.77% | -0.14% | 4.65% | 9.60% | 10.59% | Upgrade
|
| Dividend Yield | 4.49% | 4.62% | 4.68% | 6.10% | 7.25% | 7.91% | Upgrade
|
| Payout Ratio | 76.67% | 76.67% | 72.45% | 74.02% | 81.37% | 81.48% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | 0.09% | 0.05% | -0.34% | -9.73% | Upgrade
|
| Total Shareholder Return | 4.48% | 4.61% | 4.77% | 6.15% | 6.90% | -1.82% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.